BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 20422943)

  • 1. Assessment of cognitive function in patients with essential hypertension treated with lercanidipine.
    Tisaire-Sánchez J; Roma J; Camacho-Azcargorta I; Bueno-Gómez J; Mora-Maciá J; Navarro A
    Vasc Health Risk Manag; 2006; 2(4):491-8. PubMed ID: 17323604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of a lercanidipine/enalapril fixed-dose combination in hypertensive patients in Portugal.
    Maldonado J; Pereira T; Tavares A
    Drugs R D; 2014 Jun; 14(2):147-54. PubMed ID: 24831818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial.
    Mancia G; Coca A; Chazova I; Girerd X; Haller H; Pauletto P; Pupek-Musialik D; Svyshchenko Y;
    J Hypertens; 2014 Aug; 32(8):1700-7; discussion 1707. PubMed ID: 24906174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients.
    Derosa G; Bonaventura A; Romano D; Bianchi L; Fogari E; D'Angelo A; Maffioli P
    J Clin Pharm Ther; 2014 Jun; 39(3):277-85. PubMed ID: 24635387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
    Antza C; Stabouli S; Kotsis V
    Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lercanidipine/enalapril combination in the management of obesity-related hypertension.
    Grassi G
    Integr Blood Press Control; 2016; 9():69-77. PubMed ID: 27175094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fixed combination of lercanidipine and enalapril in the management of hypertension: focus on patient preference and adherence.
    Borghi C; Santi F
    Patient Prefer Adherence; 2012; 6():449-55. PubMed ID: 22791982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension.
    Rump LC
    Arzneimittelforschung; 2010; 60(3):124-30. PubMed ID: 20422943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril.
    Chatzikyrkou C; Haller H; Menne J
    Expert Opin Pharmacother; 2009 Aug; 10(11):1833-40. PubMed ID: 19527194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the fixed-dose combination lercanidipine-enalapril in renal protection.
    Egan CG; Pontremoli R
    J Nephrol; 2011; 24(4):428-37. PubMed ID: 21279953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
    Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M; Pruijm M; Wuerzner G
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.